Anand Hardikar

NHMRC Clinical trials Centre, Diabetes and Islet-Biology Group, University of Sydney

Associate Professor and Australian Future Fellow (ARC), is a researcher with specific interests and experience in non-codingRNAs / microRNAs, islet progenitor cells, epigenetics and diabetes. He currently leads research in two NHMRC project grants (one completing in 2015) and an ARC Future Fellowship grant (completing in 2016). He is the head of Diabetes and Islet Biology Group at the NHMRC Clinical Trials Centre, University of Sydney, and the vice-president of the International Islet Society, Sweden. Associate Professor Hardikar received his PhD from the University of Pune, India in December 2000 for work on pancreatic development, undernutrition and regeneration carried out jointly at the National Centre for Cell Science India and the UCL, Belgium. He received post-doctoral training in islet biology at the University of Pennsylvania School of Medicine, The University of New South Wales and then at the NIDDK, National Institutes of Health, Bethesda, USA. He started his own group in 2006 with specific focus on understanding the role of microRNAs in human pancreas development and differentiation. Associate Professor Hardikar has co-authored on over 70 research publications and eight book chapters, which have been cited over 2400 times. His h-index is 23 and i10-index is 36 (as of July 2015). Many publications have had major impacts answering some of the most important questions in beta cell biology. Twelve papers have been cited over 50 times and 3 papers more than 250 times. Research articles have appeared in leading journals such as Cell Metabolism, Science, PNAS, Biomaterials, Diabetes, JAHA, Dev Biology, Endocrinology, Methods Mol Biol and J Endocrinology.